Covagen is a startup based in Switzerland, most recent round Acquired, 2 tracked investors.
Covagen is a startup founded in 2009 based in Switzerland. Covagen has been acquired. Brouky records 2 investors associated with the company.
Covagen AG was a biopharmaceutical company that developed multispecific FynomAb® biologics for the treatment of inflammatory diseases and cancer. The company was acquired by Cilag GmbH International, a Johnson & Johnson company, in 2014.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.